Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 28 of 40 for:    Citrus reticulata

Dietary Approach to Stop Hypertension With Sodium (Na) Reduction for Chinese Canadians (DASHNa-CC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02579746
Recruitment Status : Completed
First Posted : October 20, 2015
Last Update Posted : October 20, 2015
Sponsor:
Information provided by (Responsible Party):
Ping Zou, University of Toronto

Brief Summary:
The study examined the feasibility of the Dietary Approach to Stop Hypertension with Sodium (Na) Reduction for Chinese Canadian (DASHNa-CC) intervention and its potential effects on blood pressure, health-related quality of life, and health service utilization. Half of participants received usual care while the other half received the DASHNa-CC intervention.

Condition or disease Intervention/treatment Phase
Hypertension Behavioral: DASHNa-CC Behavioral: usual care Not Applicable

Detailed Description:
Hypertension has been identified as the most important risk factor for cardiovascular diseases and accounts for a large proportion of stroke, myocardial infarction and heart failure in the Chinese population. While unhealthy diet has been identified as a modifiable risk factor for hypertension, there is a lack of culturally sensitive dietary intervention targeting Chinese Canadians. The 8-week DASHNa-CC intervention incorporated Dietary Approach to Stop Hypertension (DASH) diet, sodium reduction with the food therapy of Traditional Chinese Medicine, and included an intervention manual, two sessions of classroom instruction delivered in Mandarin, and a 20-minute telephone follow-up.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Supportive Care
Official Title: Dietary Approach to Stop Hypertension With Sodium (Na) Reduction for Chinese Canadians
Study Start Date : August 2014
Actual Primary Completion Date : December 2014
Actual Study Completion Date : August 2015

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: intervention
The intervention group received usual care plus the DASHNa-CC intervention.
Behavioral: DASHNa-CC
The 8-week DASHNa-CC intervention incorporated Dietary Approach to Stop Hypertension (DASH) diet, sodium reduction with the food therapy of Traditional Chinese Medicine, and included an intervention manual, two sessions of classroom instruction delivered in Mandarin, and a 20-minute telephone follow-up.

Behavioral: usual care
education booklet, encouragement of physician visit, use of public health resources if needed

Active Comparator: control
The control group received usual care.
Behavioral: usual care
education booklet, encouragement of physician visit, use of public health resources if needed




Primary Outcome Measures :
  1. blood pressure [ Time Frame: 8 weeks post randomization ]
    systolic and diastolic blood pressure


Secondary Outcome Measures :
  1. health related quality of life [ Time Frame: 8 weeks post randomization ]
    used SF-36v2



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   45 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • were at least 45 years old;
  • had a systolic blood pressure 140 to 159 mmHg, or a diastolic blood pressure 90 to 99 mmHg, based on pre-intervention baseline assessment;
  • were able to understand (listen) and speak in Mandarin, read and write in Chinese; and
  • had access to a telephone.

Exclusion Criteria:

  • used antihypertensive medications or other medications that raise or lower blood pressure during the previous three months;
  • used TCM or professional TCM counselling to decrease blood pressure during the previous three months;
  • used insulin or oral hypoglycemic agents during the previous three months;
  • had a history of a cardiovascular event (stroke, myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass surgery, or other arteriosclerotic cardiovascular disease related therapeutic procedure) during the previous three months;
  • had a history of congestive heart failure;
  • had a cancer diagnosis or treatment during the past two years;
  • had special dietary requirements;
  • were pregnant, breast feeding, or planned for pregnancy prior to the anticipated end of study;
  • were a household member of another DASHNa-CC participant; or
  • planned to leave the area prior to the anticipated end of study.

Layout table for additonal information
Responsible Party: Ping Zou, RN PhD, University of Toronto
ClinicalTrials.gov Identifier: NCT02579746     History of Changes
Other Study ID Numbers: UofT30496
First Posted: October 20, 2015    Key Record Dates
Last Update Posted: October 20, 2015
Last Verified: October 2015

Keywords provided by Ping Zou, University of Toronto:
hypertension
immigrant
dietary intervention
lifestyle modification

Additional relevant MeSH terms:
Layout table for MeSH terms
Hypertension
Vascular Diseases
Cardiovascular Diseases